Tubal ligation and risk of ovarian cancer [8]

Lancet

Volumn 358, Issue 9284, 2001, Pages 843-844

  Gjorgov, Arne N ^a   Piek, Jurgen M J ^b   Van Diest, Paul J ^b   Zweemer, Ronald P ^b   Kenemans, Peter ^b   Verheijen, René H M ^b   Narod, Steven ^c  

^a Vrije Universiteit Medical Center ^*  (Macedonia)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; ORAL CONTRACEPTIVE AGENT;

BIRTH CONTROL; BREAST CARCINOMA; CANCER PREVENTION; CANCER RISK; DIAGNOSTIC ERROR; FEMALE GENITAL SYSTEM; GENE MUTATION; HUMAN; LETTER; ORAL CONTRACEPTION; OVARY CARCINOMA; PRIMARY PREVENTION; PRIORITY JOURNAL; UTERINE TUBE CARCINOMA; UTERINE TUBE LIGATION;

EID: 0035828384     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)05991-8     Document Type: Letter

References (2)

1. SA Narod P Sun P Ghadirian Tubal ligation and risk of ovarian cancers of BRCA1 or BRCA2 mutations: a case-control study Lancet 357 2001 1467 1470
2. AN Gjorgov Barrier contraception and breast cancer 1980 S Karger Medical Publishers New York